4 Results for "

PKI587

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PKI587" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-10681
CAS No.: 1197160-78-3
Purity:  99.68%
Synonyms: PKI-587; PF-05212384
Target:  

PI3K mTOR

Research Areas:  

Cancer

Gedatolisib (PKI-587) is a highly potent dual inhibitor of PI3Kα, PI3Kγ, and mTOR with IC50s of 0.4 nM, 5.4 nM and 1.6 nM, respectively . Gedatolisib is equally effective in both complexes of mTOR, mTORC1 and mTORC2 .
loading...
    loading...
Cat. No.: HY-10681R
CAS No.: 1197160-78-3
Research Areas:  

Cancer

Gedatolisib (Standard) is the analytical standard of Gedatolisib. This product is intended for research and analytical applications. Gedatolisib (PKI-587) is a highly potent dual inhibitor of PI3Kα, PI3Kγ, and mTOR with IC50s of 0.4 nM, 5.4 nM and 1.6 nM, respectively . Gedatolisib is equally effective in both complexes of mTOR, mTORC1 and mTORC2 .
loading...
    loading...
Cat. No.: HY-10681S
Synonyms: PKI-587-d8; PF-05212384-d8
Gedatolisib-d8 (PKI-587-d8) is the deuterium labeled Gedatolisib (HY-10681). Gedatolisib (PKI-587) is a highly potent dual inhibitor of PI3Kα, PI3Kγ, and mTOR with IC50s of 0.4 nM, 5.4 nM and 1.6 nM, respectively. Gedatolisib is equally effective in both complexes of mTOR, mTORC1 and mTORC2 .
loading...
    loading...
Cat. No.: HY-10681S1
Synonyms: PKI-587-d6; PF-05212384-d6
Gedatolisib-d6 (PKI-587-d6) is the deuterium labeled Gedatolisib (HY-10681). Gedatolisib (PKI-587) is a highly potent dual inhibitor of PI3Kα, PI3Kγ, and mTOR with IC50s of 0.4 nM, 5.4 nM and 1.6 nM, respectively . Gedatolisib is equally effective in both complexes of mTOR, mTORC1 and mTORC2 .
loading...
    loading...